Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Arsène

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Nucleic Acids Research|July 9, 2018
Coupled catabolism and anabolism in autocatalytic RNA setsSimon Arsène, Sandeep Ameta, Niles Lehman, et al.
Nature Communications|February 9, 2021
Darwinian properties and their trade-offs in autocatalytic RNA reaction networksSandeep Ameta, Simon Arsène, Sophie Foulon, et al.
Nature Communications|April 14, 2022
Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventionsSimon Arsène, Claire Couty, Igor Faddeenkov, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2024
A quantitative systems pharmacology workflow toward optimal design and biomarker stratification of atopic dermatitis clinical trialsNatacha Go, Simon Arsène, Igor Faddeenkov, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 13, 2023
In Silico Clinical Trials: Is It Possible?Simon Arsène, Yves Parès, Eliott Tixier, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Nucleic Acids Research|July 9, 2018
Coupled catabolism and anabolism in autocatalytic RNA setsSimon Arsène, Sandeep Ameta, Niles Lehman, et al.
Nature Communications|February 9, 2021
Darwinian properties and their trade-offs in autocatalytic RNA reaction networksSandeep Ameta, Simon Arsène, Sophie Foulon, et al.
Nature Communications|April 14, 2022
Modeling the disruption of respiratory disease clinical trials by non-pharmaceutical COVID-19 interventionsSimon Arsène, Claire Couty, Igor Faddeenkov, et al.
The Journal of Allergy and Clinical Immunology|February 18, 2024
A quantitative systems pharmacology workflow toward optimal design and biomarker stratification of atopic dermatitis clinical trialsNatacha Go, Simon Arsène, Igor Faddeenkov, et al.
Methods in Molecular Biology (Clifton, N.J.)|September 13, 2023
In Silico Clinical Trials: Is It Possible?Simon Arsène, Yves Parès, Eliott Tixier, et al.
Pageof 1